In vivo kinetics of 111Indium‐labelled autologous granulocytes following i.v. administration of granulocyte‐macrophage colony‐stimulating factor (GM‐CSF)
Authors:
- 24 April 1992
- journal article
- clinical trial
- Published by Wiley in European Journal of Haematology
- Vol. 48 (4) , 202-207
Abstract
Abstract: Administration of both glycosylated and non‐glycosylated recombinant human granulocyte‐macrophage colony‐stimulating factor (rhGM‐CSF) induces an immediate transient granulocytopenia of 1–3 hours' duration. In order to explore this phenomenon, granulocytes were labelled with 111Indium and the effect on the kinetics of granulocytes after administration of rhGM‐CSF was studied in 10 previously untreated patients with malignant lymphoma. For both types and doses of rhGM‐CSF, a significant and dramatic accumulation of the 111Indium‐labelled granulocytes was observed in the lung within a few minutes after i.v. injection of rhGM‐CSF. The accumulation of radioactivity coincided with the pronounced and transient granulocytopenia in peripheral blood. The 111Indium‐labelled granulocytes later reappeared in the peripheral blood, indicating reversible pulmonary vascular margination of the granulocytes. Half‐life of labelled granulocytes after reappearance was comparable to half‐life values under normal conditions. The transient accumulation of granulocytes in the pulmonary vessels seems not to be of clinical importance in the management of patients, but it may to some degree explain previously described side‐effects, such as transient hypoxemia (“first‐dose” reaction) following administration of rhGM‐CSF.Keywords
This publication has 29 references indexed in Scilit:
- Clinical pharmacokinetic studies of a human haemopoietic growth factor, GM‐CSFEuropean Journal of Clinical Investigation, 1992
- Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Related Neutropenia in Patients with Non-Hodgkin's Lymphomas—A Phase I/II Study of Dose and Mode of AdministrationLeukemia & Lymphoma, 1991
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- TRANSIENT LEUCOPENIA INDUCED BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORThe Lancet, 1987
- Neutrophils in Human DiseasesNew England Journal of Medicine, 1987
- Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- Human granulocyte-macrophage colony-stimulating factor is a neutrophil activatorNature, 1985
- Increased Expression of an Adhesion-Promoting Surface Glycoprotein in the Granulocytopenia of HemodialysisNew England Journal of Medicine, 1985
- LEUKOKINETIC STUDIES. IV. THE TOTAL BLOOD, CIRCULATING AND MARGINAL GRANULOCYTE POOLS AND THE GRANULOCYTE TURNOVER RATE IN NORMAL SUBJECTS*Journal of Clinical Investigation, 1961